Focused on powering the future of ocular drug delivery.
As we continue to witness the ageing of the global population, so too we see the rise in prevalence of age-related diseases such as Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Retinal Vein Occlusion (RVO) and Glaucoma.
As a result, ophthalmic drug delivery grows in prominence too, thanks to its patient centric design featuring easy preparation and application, accurate dosing and as a result, high levels of patient compliance.
With over two decades experience and expertise in providing sterile manufacturing excellence, we aim to be your strategic development partner of choice for ophthalmology, guiding products from early-stage research right through to the clinic and onto commercialisation.
The platform offers pharmaceutical partners tangible benefits; being a proven delivery solution that supports product differentiation and lifecycle management. Our comprehensive development services support our partners in formulation and product development for solutions, suspensions and emulsions. Our expert team also delivers device selection studies, method development as well as sterility and stability testing.
For partners in early and mid-phase clinical programmes our clinical filling capabilities are designed to fill multidose preservative free systems, utilising isolator and semi-automated filling process.
Key Benefits for Pharmaceutical Partners
Key Benefits for Patients

image: 2687331997@shutterstock.com